Regen BioPharma Inc (RGBP)

[Jack Torrance]

No one can predict that. That would be a negotiation between Regen and the buying party, based on their perceived value of Regen's intellectual property.

I personally think a buyout in the next few months could be in the $5-$10 billion range, if Regen just wants a quick buyout ... which would be roughly in the $1.25 to $2.50 per share range.

If, however, a buyout comes farther down the line, when Regen has demonstrated that their tech does in fact work on tumorous cancers, then a buyout would be much higher, IMO ... perhaps in the $40 to $60 billion range, which would be about $12 to $15 per share.